FIELD: biotechnologies.
SUBSTANCE: application describes compositions and methods of nerve cells visualisation. A composition contains a virus component bound with a fluorescent dye to produce a complex, which is capable of penetration into nerve cells, where the virus component is selected from a neurotropic replication-defect virus, a virus protein of the neurotropic virus and capsid of the neurotropic virus.
EFFECT: reduced risk of iatrogenic damage of nerves in medicine.
19 cl, 23 dwg, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC COMPOSITIONS AND METHODS OF USING FOR TREATING CANCER | 2016 |
|
RU2720984C2 |
| RNAi AGENT OPTION | 2018 |
|
RU2789647C2 |
| VECTORS CONTAINING SPACER/FILLER POLYNUCLEOTIDE SEQUENCES, AND METHODS OF USING THEM | 2014 |
|
RU2725813C2 |
| MODIFIED CAPSID PROTEINS FOR IMPROVED DELIVERY OF PARVOVIRUS VECTORS | 2016 |
|
RU2751953C2 |
| RECOMBINANT ADEN-ASSOCIATED VIRUS, WHICH IS HYBRID OF AAV9 AND AAVrh74 SEROTYPES, WITH REDUCED TROPISM FOR LIVER TISSUE | 2019 |
|
RU2812279C2 |
| VIRIONS OF AN ADENO-ASSOCIATED VIRUS WITH A VARIANT CAPSID AND METHODS FOR USING THEM | 2017 |
|
RU2742724C1 |
| GENE EDITING OF DEEP INTRON MUTATIONS | 2016 |
|
RU2759335C2 |
| GENE THERAPY FOR NEURODEGENERATIVE DISORDERS | 2010 |
|
RU2603740C2 |
| GENE THERAPY OF NEURODEGENERATIVE DISORDERS | 2010 |
|
RU2743398C2 |
| ADENO-ASSOCIATED VIRUS VECTOR | 2015 |
|
RU2743382C2 |
